Bone engineering: Combining smart biomaterials and the application of stem cells

Artificial Organs

Volumn 30, Issue 10, 2006, Pages 770-774

  Lechner, Sarah ^a   Huss, Ralf ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Angiogenic and osteogenic differentiation; Bone tissue; Composite grafts; Differentiation; Mesenchymal stem cells; Multipotent adult progenitor cells; Proliferation; Regenerative medicine; Stem cells

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL ENGINEERING; HISTOLOGY; HYDROXYAPATITE; REGENERATIVE MEDICINE; REPAIR; STEM CELLS; TISSUE ENGINEERING;

ANGIOGENIC AND OSTEOGENIC DIFFERENTIATION; BONE TISSUE; COMPOSITE GRAFT; DIFFERENTIATION; MESENCHYMAL STEM CELL; MULTIPOTENT ADULT PROGENITOR CELL; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELL; PROLIFERATION; REGENERATIVE MEDICINE; STEM-CELL;

CELL CULTURE;

BIOMATERIAL; CALCIUM PHOSPHATE; COLLAGEN; FIBRIN; HYDROXYAPATITE; THROMBIN;

ANGIOGENESIS; ANIMAL CELL; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE TISSUE; BONE TRANSPLANTATION; COMPOSITE GRAFT; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; GRAFT SURVIVAL; IN VITRO STUDY; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE STRUCTURE; TISSUE TRANSPLANTATION;

ANIMALIA; MURINAE;

EID: 33749504477     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00299.x     Document Type: Conference Paper

References (14)

1. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004;36:568-84.
2. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005;2:8.
3. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 2004;22:136-41.
4. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
5. Pawelec G, Rehbein A, Schlotz E, Friccius H, Pohla H. Cytokine modulation of TH1/TH2 phenotype differentiation in directly alloresponsive CD4+ human T cells. Transplantation 1996;62:1095-101.
6. Lange C, Kaltz C, Thalmeier K, Kolb HJ, Huss R. Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(Low), C-Kit+ stem cell line. J Hematother Stem Cell Res 1999;8:335-42.
7. Meirelles, Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol, 2003;123:702-11.
8. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994;15:490-5.
9. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 1989;170:399-414.
10. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
11. Chaudhry GR, Yao D, Smith A, Hussain A. Osteogenic cells derived from embryonic stem cells produced bone nodules in three-dimensional scaffolds. J Biomed Biotechnol 2004;4:203-10.
12. Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001;7:1032-9.
13. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery 2006;58:373-80.
14. Schneider KI. Fibrin sealants in surgical or traumatic hemorrhage. Curr Opin Hematol 2004;11:323-6.